126 related articles for article (PubMed ID: 26854809)
1. Risk of cancer in children exposed to didanosine in utero.
Hleyhel M; Goujon S; Delteil C; Vasiljevic A; Luzi S; Stephan JL; Reliquet V; Jannier S; Tubiana R; Dollfus C; Faye A; Mandelbrot L; Clavel J; Warszawski J; Blanche S;
AIDS; 2016 May; 30(8):1245-56. PubMed ID: 26854809
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience.
Hleyhel M; Goujon S; Sibiude J; Tubiana R; Dollfus C; Faye A; Mandelbrot L; Clavel J; Warszawski J; Blanche S;
Environ Mol Mutagen; 2019 Jun; 60(5):404-409. PubMed ID: 29206312
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
Benhammou V; Warszawski J; Bellec S; Doz F; André N; Lacour B; Levine M; Bavoux F; Tubiana R; Mandelbrot L; Clavel J; Blanche S;
AIDS; 2008 Oct; 22(16):2165-77. PubMed ID: 18832880
[TBL] [Abstract][Full Text] [Related]
4. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
[TBL] [Abstract][Full Text] [Related]
5. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
6. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
7. Altered heterochromatin organization after perinatal exposure to zidovudine.
Senda S; Blanche S; Costagliola D; Cibert C; Nigon F; Firtion G; Floch C; Parat S; Viegas-Péquignot E
Antivir Ther; 2007; 12(2):179-87. PubMed ID: 17503660
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk among HIV-exposed uninfected children in the United States.
Horner MJ; Hazra R; Barnholtz-Sloan JS; Shiels MS; Engels EA
AIDS; 2023 Mar; 37(3):549-551. PubMed ID: 36544264
[TBL] [Abstract][Full Text] [Related]
9. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).
Sibiude J; Mandelbrot L; Blanche S; Le Chenadec J; Boullag-Bonnet N; Faye A; Dollfus C; Tubiana R; Bonnet D; Lelong N; Khoshnood B; Warszawski J
PLoS Med; 2014 Apr; 11(4):e1001635. PubMed ID: 24781315
[TBL] [Abstract][Full Text] [Related]
10. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
[TBL] [Abstract][Full Text] [Related]
12. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
13. No relation between in-utero exposure to HAART and intrauterine growth retardation.
Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
[TBL] [Abstract][Full Text] [Related]
14. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
[TBL] [Abstract][Full Text] [Related]
16. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.
Powis KM; Smeaton L; Hughes MD; Tumbare EA; Souda S; Jao J; Wirth KE; Makhema J; Lockman S; Fawzi W; Essex M; Shapiro RL
AIDS; 2016 Jan; 30(2):211-20. PubMed ID: 26684818
[TBL] [Abstract][Full Text] [Related]
17. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Albano JD; Koram N; Tilson H; Scheuerle AE; Napier MD
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():6-10. PubMed ID: 26687320
[TBL] [Abstract][Full Text] [Related]
19. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
[TBL] [Abstract][Full Text] [Related]
20. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
